Healthy Skepticism Library
Items published during the years 1990 to 1999
There are 2218 items in the Healthy Skepticism Library that were published during the years 1990 to 1999.
Page 5 of 23 pages ‹ First < 3 4 5 6 7 > Last ›
HSL386
Parker BJ, Delene LM.
Direct-to-consumer prescription drug advertising: content analyis and public policy implications
Journal of Pharmaceutical Marketing & Management 1998; 12:(4):27
HSL395
Lexchin J.
Improving the appropriateness of physician prescribing.
Int J Health Serv 1998; 28:(2):253-67
HSL1897
Creyer EH, Hrsistodoulakis I.
Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry
Mark Health Serv. 1998 Sum; 18:(2):34-8
HSL2009
Bourguignon R.
Problems with Prozac
1998
HSL2332
Powers R
Time with drug reps affects prescribing.
1998
HSL3704
Brown P.
Will DTC advertising shape the future of the industry?
Scrip Mag. 1998; 3-4
HSL5315
Beck JM, Azari ED.
FDA, off-label use, and informed consent: debunking myths and misconceptions.
Food Drug Law J 1998; 53:(1):71-104
HSL5370
Pizor , TC .
A medical publisher reminds us: don't forget the gatekeepers
Med Mark Media 1998; 33:65-67
HSL6324
O-Brien KL.
Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning
JAMA 1998; 279:1180
HSL6777
Medicating for a mirage
International Journal of Risk & Safety in Medicine 1998; 11:1-3
HSL6778
National survey of consumer reactions to direct-to-consumer advertising
Pennsylvania: Rodale Press 1998
HSL6779
Spotlight: BMS vs CCOHTA
Connection 1998
www.ccohta.ca
HSL6780
Ault A.
US FDA ordered to allow off-label data dissemination
Lancet 1998; 352:555
HSL6781
Bauer G.
Pitching drugs to patients
Pharmacy Practice 1998; 14:(12):43-44, 46, 48
www.pharmacyconnects.com/pharPrac/index.htm
HSL6782
Baylor-Henry M, Drezin NA.
Regulation of prescription drug promotion: direct-to-consumer advertising.
Clin Ther 1998; 20:
HSL6783
Brock TP, Smith MC.
A content analysis of the appeals used in advertising in the Americal Journal of Hospital Pharmacy in 1960, 1970, 1980, and 1990
Journal of Pharmaceutical Marketing & Management 1998; 12:(4):43
HSL6784
Center for Drug Evaluation and Research
CDER 1997: report to the nation
: U.S. Department of Health and Human Services 1998
HSL6785
Day M.
He who pays the piper . . .
New Scientist 1998; 158:(2133):18-19
HSL6786
Fried S.
Bitter pills: inside the hazardous world of legal drugs
New York: Bantam Books 1998
HSL6788
Gutkin C.
Pharmaceutical industry and the medical profession
Canadian Family Physician 1998; 44:1756
HSL6789
Hoey J.
Placing the ads
Canadian Medical Association Journal 1998; 159:920
http://www.cma.ca/cmaj/vol-159/issue-8/0920b.htm
HSL6790
Kassirer J.
Cal Ripken, Jr., and prinivil
New England Journal of Medicine 1998; 339:2025
HSL6791
Lexchin J.
Placing the ads
Canadian Medical Association Journal 1998; 159:920
http://www.cma.ca/cmaj/vol-159/issue-8/0920a.htm
HSL6792
Lexchin J.
The relationship between pharmaceutical regulation and inappropriate prescribing: the case of psychotropic drugs in Canada during the 1960s and early 1970s
International Journal of Risk & Safety in Medicine 1998; 11:49-59
HSL6793
Lexchin J, North P.
OMA perspective on comparative advertising of pharmaceutical products
Ontario Medical Review 1998; 65:(5):25-27
HSL6794
Mintzes B
Blurring the boundaries: new trends in drug promotion
Amsterdam: Health Action International 1998
www.haiweb.org
HSL6795
Morgan S
Issues for Canadian pharmaceutical policy: Striking a balance: health care systems in Canada and elsewhere
Sainte-Foy, Canada: Sainte-Foy, Canada 1998
HSL6796
Powers RL, Halbritter KA, Arbogast JG, Neely JL, Williams AJ.
Do interactions with pharmaceutical representatives influence antihypertensive medication prescribing practices of family medicine and general internal medicine physicians?
Journal of General Internal Medicine 1998; 13:13
HSL6797
Shannon TM.
Trials of CCBs
Canadian Medical Association Journal 1998; 158:21-23
http://www.cma.ca/cmaj/vol-158/issue-1/0021b.htm
HSL6799
Sherwood LM.
Cal Ripken, Jr., and prinivil
New England Journal of Medicine 1998; 339:2025
HSL6800
Valpy M.
Science friction
Elm Street 1998; 26-28, 30, 32, 34-36
HSL6811
McCormack J.
Drug ad hard to swallow
Adbusters 199818-19
www.adbusters.org/adbusters/
HSL8092
Pines WL.
Direct-to-consumer promotion: an industry perspective.
Clin Ther 1998; 20:
HSL8093
Maine LL.
Direct-to-consumer advertising: a pharmacy perspective.
Clin Ther 1998; 20:
HSL8115
Doucette WR, Schommer JC.
Consumer preferences for drug information after direct-to-consumer advertising
Drug Information Journal 1998; 34:(4):1081-1088
HSL8154
McCaffrey DJ, Smith MC, Banahan BF, Frate DA, Gilbert FW.
Continued look into the financial implications of initial noncompliance in community pharmacies: unclaimed prescription audit pilot
Journal of Research in Pharmaceutical Economics 1998; 9:(2):33-57
HSL8156
Wechsler J.
Message to marketers: take the high road
Pharmaceutical Executive 1998; 1:(2):28-29
HSL8158
Smith D.
It's our health...and we want more than advertising
Pharmaceutical Executive 1998; 1:(2):23-24
HSL8159
DTC data
Pharmaceutical Executive 1998; 1:(2):33-34
HSL8170
Muse DN.
Medicaid's transition into managed care? Real or imaginary?
Pharmacoeconomics. 1998; 14:(Suppl 1):57-67.
http://www.ncbi.nlm.nih.gov/pubmed/10186483
HSL8171
Lasagna L.
Defining our future work.
Pharmacoeconomics 1998; 14:
HSL9085
Moynihan R.
Too much medicine? The Business of Health - and Its Risks for You
Sydney: ABC Books 1998
http://www.amazon.com/Too-Much-Medicine-Business-Health/dp/B000OHCGS8/ref=sr_1_4/102-1249992-1219339?ie=UTF8&s=books&qid=1175306755&sr=1-4
HSL9203
Rozek RP.
Critique of the GAO report on differences in prices for prescription drugs between Canada and the United States
Journal of Research in Pharmaceutical Economics 1998 Mar; 6:(1):77-91
HSL11547
Miller D.
Mediating Science: promotional strategies, media coverage, public belief and decision making
Scanlon E, Whitelegg E, Yates S. Communicating Science: Contexts and Channels London: Routledge/Open University 1998
http://www.amazon.com/Communicating-Science-Contexts-Channels-University/dp/041519752X/ref=sr_1_14/102-5869202-0212934?ie=UTF8&s=books&qid=1190545477&sr=1-14
HSL13287
Keller KL.
Strategic Brand Management: Building, Measuring, and Managing Brand Equity
New Jersey: Prentice Hall 1998
http://www.pearsonhighered.com/bookseller/academic/product/0,3110,0131888595,00.html
HSL13374
Lapeyre-Mestre M, Desboeuf K, Aptel I, Chale JJ, Montastruc JL.
A comparative survey of antidepressant drug prescribing habits of general practitioners and psychiatrists.
Clin Drug Investig 1998; 16:(1):53-61
http://www.ncbi.nlm.nih.gov/pubmed/18370518
HSL18028
Peyrot M, Alperstein NM, Van Doren D, Poli LG
Direct-to-consumer ads can influence behavior. Avertising increases consumer knowledge and prescription drug requests.
Mark Health Serv 1998; 18:(2):26-32.
http://www.ncbi.nlm.nih.gov/pubmed/10180332
HSL18353
Glinert LH
Side effect warnings in British medical package inserts: A discourse analytical approach
International Journal of Cognitive Ergonomics 1998; 2:(1-2):61-74
HSL19869
Misleading promotions in Australia
Scrip 1997 Dec 26;
HSL535
Menkes DB.
Hazardous drugs in developing countries.
BMJ 1997 Dec 13; 315:(7122):1557-8
http://bmj.bmjjournals.com/cgi/content/full/315/7122/1557
HSL548
Lewin-Fetter V.
Pharmaceutical representatives.
Lancet 1997 Dec 13; 350:(9093):1784
HSL19930
Leighton G, Telford ME
Evidence based advertising?: Reply from manufactuter
BMJ 1997 Dec 13; 315:1621
HSL19931
Hamet P
Reply from author of STONE study
BMJ 1997 Dec 13; 315:1621-1622
HSL19932
Mindell J, Kemp T
Evidence based advertising? Only two fifths of advertisements cited published, peer reviewed references.
BMJ 1997 Dec 13; 315:1622
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127972/
HSL19933
Crane S
Evidence based advertising? 'Cash for questions' is not limited to MPs.
BMJ 1997 Dec 13; 315:1622
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127977/
HSL19934
Smart S, Williams C
Half of drug advertisements in BMJ over six months cited no supporting evidence
BMJ 1997 Dec 13; 315:1622-3
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127981/
HSL19935
Greenhalgh T.
Advertisements for donepezil. More convincing evidence of efficacy needs to be cited.
BMJ 1997 Dec 13; 315:1623
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127985/
HSL19936
Stein K, Milne R, Best L
Advertisements for donepezil. BMJ should require advertisements to detail actual state of evidence.
BMJ 1997 Dec 13; 315:1623
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127989/
HSL19937
Wilkinson D
Advertisements for donepezil. Review of drug in Drug and Therapeutics Bulletin is uninformed
BMJ 1997 Dec 13; 315:1625
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127997/
HSL19964
Hamet P
Evidence based advertising?: Reply from author of STONE study
BMJ 1997 Dec 13; 315:1622
http://www.jstor.org/discover/10.2307/25176531?uid=3737536&uid=2129&uid=2134&uid=2&uid=70&uid=4&sid=55871785133
HSL19965
Boothby H, Zaidi SMN, Seth V, Khalaf S, Jameel H, Mahomed S, Al-Yassiri
Advertisements for donepezil: National policy to be set for prescribing of this drug
BMJ 1997 Dec 13; 315:1624
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127992/
HSL19966
Hooper P, Whitehead AM
Advertisements for donepezil: Drug company's reply
BMJ 1997 Dec 13; 315:1624
http://www.jstor.org/discover/10.2307/25176532?uid=3737536&uid=2129&uid=2134&uid=2&uid=70&uid=4&sid=55871785133
HSL19967
Jones RW, Mann JB, Saunders SA
Advertisements for donepezil. Prices charged for private prescriptions for donepezil show huge variation.
BMJ 1997 Dec 13; 315:(7122):1624
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127995/
HSL18031
Greenhalgh T, Gill P.
Pressure to prescribe.
BMJ 1997 Dec 6; 315:(7121):1482-3
http://www.bmj.com/cgi/content/extract/315/7121/1482
HSL18032
Britten N, Ukoumunne O.
The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey.
BMJ 1997 Dec 6; 315:(7121):1506-10
http://www.bmj.com/cgi/content/full/315/7121/1506?view=long&pmid=9420493
HSL1550
Mansfield PR.
MaLAM, a medical lobby for appropriate marketing of pharmaceuticals.
Med J Aust 1997 Dec 1-15; 167:(11-12):590-2
http://www.mja.com.au/public/issues/xmas/mansfield/mansfield.html
HSL8228
Americans at risk from self-medication, survey reveals
American Journal of Health System Pharmacy 1997 Dec 1; 54:2664, 2666
HSL544
Lipsky MS, Taylor CA.
The opinions and experiences of family physicians regarding direct-to-consumer advertising.
J Fam Pract 1997 Dec; 45:(6):495-9
HSL6776
Mansfield P, Vitry A.
Re: the promotion of prescription products in Australia
1997 Dec;
HSL8176
Tanouye E, Langreth R.
U.S. drug patents
Eastern Pharmacist 1997 Dec; 40:21-24
HSL8182
Reissman D.
Who's taking the risk for prescription drug costs?
Drug Benefit Trends 1997 Dec; 9:19
HSL8185
Wechsler J.
Direct-to-marketers: FDA talks to the industry
Pharmaceutical Executive 1997 Dec; 17:52-54, 56, 58, 60, 62
HSL8222
Wechsler J.
Final reform bill modernizes FDA, permits dissemination of off-label and economic data
Formulary 1997 Dec; 32:1253-1254
HSL8240
Hicks AR, Jackson MW, Barnard JF.
Pharmacoeconomic strategies for treating HIV patients in an indigent clinic
ASHP Midyear Clinical Meeting 1997 Dec; 32:
HSL8241
Habowski SR, Robinson SM, Kalis D.
Establishing an indigent prescription program in the ambulatory care setting
ASHP Midyear Clinical Meeting 1997 Dec; 32:
HSL13248
Aaker JL, Maheswaran D.
The Effect of Cultural Orientation on Persuasion
Journal of Consumer Research 1997 Dec; 24:(3):315-27
http://www.journals.uchicago.edu/doi/abs/10.1086/209513
HSL580
Alliot L.
Quality of drug advertisements in medical journals.
Lancet 1997 Nov 29; 350:(9091):1636
HSL6768
Chiu JT.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Nov 19; 278:(19):1568
HSL6769
Limaye AP, Paauw DS.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Nov 19; 278:(19):1568-9
HSL6770
Margolis LH.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Nov 19; 278:(19):1567
HSL6771
Mehta HJ.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Nov 19; 278:(19):1568
HSL6772
Reynolds S.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Nov 19; 278:(19):1567-8
HSL6773
Rosner F.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Nov 19; 278:(19):1567
HSL6774
Tenery RM Jr.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Nov 19; 278:(19):1568
HSL6775
Westfall J, McCabe J, Nicholas RA.
Personal use of drug samples by physicians and office staff [reply]
JAMA 1997 Nov 19; 278:(19):1569
HSL418
Vitry A, Mansfield P.
Drug advertisements in medical journals.
Lancet 1997 Nov 15; 350:(9089):1477-8
http://www.thelancet.com/search/results?search_searchuri=%2Fsearch%2Fadvanced&search_resulturi=%2Fsearch%2Fresults&search_preview=no&search_reqfirst=1&search_reqcount=20&search_submode=advanced&update_search=no&search_mode=platform&search_cluster=phoenix&search_text1=Vitry+A&search_within1=au&search_operator1=and&search_text2=Mansfield+P&search_within2=au&search_operator2=and&search_text3=advertisements&search_within3=ti&restrictterm_lancet=lancet&restrictname_lancet=lancet&restricttype_lancet=journal&restrictdesc_lancet=The+Lancet&restrictname_laneur=laneur&restricttype_laneur=journal&restrictdesc_laneur=The+Lancet+Neurology&restrictname_laninf=laninf&restricttype_laninf=journal&restrictdesc_laninf=The+Lancet+Infectious+Diseases&restrictname_lanonc=lanonc&restricttype_lanonc=journal&restrictdesc_lanonc=The+Lancet+Oncology&search_dateradio=combo&search_datecombo=0%3AALL&search_monthstartcombo=1&search_yearstart=1996&search_monthendcombo=1&search_yearend=2005&search_wordsexactly=yes&search_sort=relevance&Submit=Search
HSL564
Flegel KM.
Physicians, finder's fees and free, informed consent.
CMAJ 1997 Nov 15; 157:(10):1373-4
http://www.cma.ca/cmaj/vol-157/issue-10/1373.htm
HSL8230
Rothermich EA, Pathak DS.
References for health-related quality-of-life claims in prescription drug advertisements.
Am J Health Syst Pharm 1997 Nov 15; 54:(22):2596-9
http://www.ajhp.org/cgi/reprint/54/22/2596
HSL18030
Dent TH, Hawke S.
Too soon to market.
BMJ 1997 Nov 15; 315:(7118):1248-9
http://www.bmj.com/cgi/content/full/315/7118/1248?view=long&pmid=9390044
HSL16732
Sasich LD, Wolfe SM, Pearson C, Swankin DA, Levin AA, Beard J.
The National Council on Patient Information and Education.
JAMA 1997 Nov 12; 278:(18):1491-2
http://www.ncbi.nlm.nih.gov/pubmed/9363963
HSL545
Lexchin J.
Code of marketing practices.Voluntary self-regulation for the Pharmaceutical Manufacturers Association of Canada
Can Fam Physician. 1997 11 01; 43:
HSL560
Guyatt G.
Determining an ethical stance: Pharmaceutical industry involvement and family medicine residency training
Can Fam Physician 1997 Nov 01; 43:1898-900
HSL540
Mahood S, Zagozeski C, Bradel T, Lawrence K.
Pharmaceutical policies in Canadian family medicine training. Survey of residency programs
Can Fam Physician 1997 Nov; 43:1947-51
HSL1866
Shaughnessy AF, Bucci KK.
Drug samples and family practice residents.
Ann Pharmacother 1997 Nov; 31:(11):1296-300
HSL6762
Christensen TP, Ascione FJ, Bagozzi RP.
Understanding how elderly patients process drug information: a test of a theory of information processing.
Pharm Res 1997 Nov; 14:(11):1589-96
http://www.springerlink.com/content/j710827lt8226251/
HSL6763
Lumley P.
Forging closer links with patients
Scrip Magazine 1997 Nov; (62):19-20
www.pjbpubs.co.uk/scrip/scrhome.html
HSL6764
Prettejohn R.
Making the most of meetings
Scrip Magazine 1997 Nov; (62):11-12
HSL6765
Sorell T.
Sponsors, ethics and the NHS
Scrip Magazine 1997 Nov; (62):7-9
www.pjbpubs.co.uk/scrip/scrhome.html
HSL6766
Weinblatt L.
DTC advertisers—you’re wasting your money
Medical Marketing & Media 1997 Nov; 32:(11):47-51
HSL6767
Sweet M.
Healthy profits (part 3)
MaLAM International News 1997 Nov-Dec; 15:(11-12):1-4
Page 5 of 23 pages ‹ First < 3 4 5 6 7 > Last ›
